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THE ACETYLCHOLINE "BLOCKING EFFECT" OF "ANTIHISTA-
MINIC" DRUGS AS MEASURED BY ELECTROPHORESIS OF
MECHOLYL IN HUMAN SUBJECTS*
DANIEL J. PERRY, M.D., JOHN A. HOSMER, M.D. AND
THOMAS H. STERNBERG, M.D.
An objective method of measuring the activity of the so-called "antihista-
minic" drugs in human subjects has been described by Perry, Falk and Pillsbury
(1). The production of cutaneous whealing by the iontophoresis of histamine
dilutions enabled these authors, and later Sternberg, Perry and LeVan (2) to
evaluate the "histamine-blocking" effect of a number of these compounds.
It is well established that skin whealing can also be produced by the ionto-
phoresis of acetyicholine (3, 4) and some of its synthetic derivatives, including
Mecholyl (5). In animals the "antihistaminic" drugs have been shown to have
an acetyicholine "blocking effect" (6). In order to measure this action in humans,
modifications of the iontophoresis whealing technic utilizing serial dilutions of
Mecholyl in place of histamine were employed. This paper describes the technic
developed and its application to the determination of the degree and duration
of the acetylcholine "blocking effect" of single oral dosages of Benadryl, Pyri-
benzamine and controls.
MATERIALS AND METHODS
The apparatus used for electrophoresis consists of two 45 Volt B batteries in series, con-
nected in series with a rheostat and ammeter. The positive electrode is a 1.75 sq. cm. piece
of fourteen gauge sheet copper. The negative electrode is a 7 sq. cm. asbestos pad.
Dilutions of Mecholyl (acetyl-beta methyicholine chloride) ranging from 1:10 to 1:1000
are freshly prepared for each experiment using 1.0 gram bottles (U.S .P. Merck). Mecholyl
is a synthetic choline ester which exerts its characteristic effects in the body in a manner
similar to acetylcholine (5). It is less readily hydrolyzed by cholinesterase than acetyl-
choline therefore has a longer period of action in the tissues (5). Mecholyl is relatively freer
of nicotinic effects, a function which is not evaluated in the present experiments (5). Mech-
olyl is also used because it is stable in solution (5) whereas acetylcholine is not.
The diluent is a specially prepared buffered neutral solution.' The dilutions most corn-
nionly used are shown in Table 1.
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1 Diluent Solution:
Stock solution—20 cc., NaCl—8.50 gm., Distilled water, q.s.—1000 cc.
The composition of stock solution is as follows: NaH2PO4—28.81 gm., Na,HPO4—
125.00 gm.
Distilled water, q.s.—1000 cc.
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A piece of filter paper (No. 50 Whatman) 1.75 sq. cm. is saturated with the dilution to be
tested, placed on the flexor surface of the forearm of the test subject and covered with the
positive (copper) electrode. A constant weight, equally suspended on each side of the fore-
arm, is then superimposed. This weight consists of stockinette, each end of which encloses
a sand filled bottle weighing 0.2 kg. The negative electrode is grasped in the hand of the
extremity employed for testing. A four milliampere current is then induced and maintained
for four minutes, following which the test site is carefully observed for ten minutes for a
whealing reaction. The solutions are tested in series to determine the threshold level which
is the highest dilution producing diffuse punctate follicular whealing at the test site. The
diluent solution, similarly tested, serves as a control for each series of tests. The positive
electrode is washed with tap water and carefully dried before reuse. The filter paper squares
are used for one test only. The solutions are frequently stirred.
A galvanic system with a 90 volt potential was found necessary to provide proper current
control. Each of six subjects was tested using both a 45 volt and a 90 volt source. It was
shown that the threshold dilution was the same regardless of potential. However, in a ran-
TABLE 1
Tabulation of serial mecholyl dilutions and their corresponding concentration
MCHOLYL DILtTTION ZCEOLYL DILUTiON OMS MECHOLYL PER
1:10 0.100 1:30 0.033
1:11 0.090 1:40 0.025
1:12 0.083 1:50 0.020
1:13 0.076 1:75 0.013
1:14 0.071 1:100 0.010
1:15 0.066 1:125 0.008
1:16 0.062 1:150 0.066
1:17 0.058 1:175 0.057
1:18 0.055 1:200 0.005
1:19 0.052 1:250 0.004
1:20 0.050 1:325 0.003
1:22.5 0.044 1:500 0.002
1:25 0.040 1:1000 0.001
dom series of individuals, it was found that the requisite 4 milliamperes current could not
always be obtained with a 45 volt circuit.
Various time-current factors were evaluated. Tests were made on ten subjects using two
milliamperes of current for two minutes. The thresholds were of low order (1:1 to 3:1) and
several failed to show a whealing reaction. Tests in other subjects demonstrated that the
combination of four milliamperes current for four minutes is satisfactory. Using these fac-
tors the thresholds are found to range from 1:1000 (0.001 grams Meeholyl/cc. of sol.) to
1:15 (0.066 grams Mecholyl/ec. of sol.), the majority occurring in dilutions greater than
1:150 (0.0066 grams Meeholyl/cc. of sol.). Determinations are facilitated by using "pilot"
dilutions of 1:10, 1:50, 1:150, 1:250 and 1:500. When the approximate level of the threshold
has been determined, the actual threshold is found by testing the serial dilutions within
that range.
The threshold obtained at different levels of the flexor surface of the forearm
seemed to vary. In each of ten subjects the threshold dilution was determined.
Using the same solution, different areas on the flexor surface of each forearm
were tested. In all subjects no change in intensity of whealing reaction was
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obtained in the area extending from the antecubital fold to a line seven to eight
centimeters proximal to the palm. Distal to this point whealing was either di-
minished or absent. These findings were similar to those obtained in histamine
iontophoresis studies (1).
Initial thresholds were determined in 12 subjects who received no medication.
Retesting of individual threshold levels at hourly intervals for a period of 3—6
hours showed no change. Activities, such as eating and sleeping between tests,
did not alter the threshold. On different days the same subject may not have
the same threshold, therefore determination of this level is necessary each day
a subject is tested.
After the initial threshold reaction was determined 50 mgm. of Benadryl or
Pyribenzamine or an inert placebo control was administered orally. Subsequently,
the threshold dilution was redetermined at one hour intervals for five hours.
If the threshold dilution did not return to its initial level in five hours, a six
hour determination was made.
TABLE 2
Average grams mecholyl per c.c. solution "blocked" cit hourly intervals by 50 mgm. of benadryl
in 25 subjects
BOURLT THRESHOLD INITIAL 1 HOUR 2 HOUR 3 HOUR 4 HOUR 5 HOUR
Average threshold (grams mecholyl/cc.
sol.) 0080 .0193 .0231 .0203 .0124 .0093
Average initial threshold (grams mecho-
lyI/cc. sol.) 0089 .0089 .0089 .0089 .0089 .0089
Average mecholyl "blocked" (grams
mecholyl/cc. sol.) (difference) 0000 .0104 .0142 .0114 .0035 .0004
EXPERIMENTAL RESULTS
Tests were performed on 46 subjects of whom 36 were males and 10 females.
The average age of the subjects tested was 29. A total of 70 tests were made,
25 following Benadryl, 25 after Pyribensamine and 20 controls. All experiments
were begun 1—1k hours after meals and no drugs were administered for at least
24 hours before testing.
All threshold dilutions were converted to their corresponding Mecholyl con-
centrations. As seen in Table 1, each threshold dilution contains a definite con-
centration of Mecholyl (gms./cc sol.). All initial and hourly threshold dilutions
in each of the 25 Benadryl tested subjects were converted to their corresponding
Mecholyl concentrations (Table 1). The average for these 25 subjects was then
determined for the initial, 1, 2, 3, 4, and 5 hour threshold readings and found
to be .00892, .01932, .0231, .02032, .01242 and .00932 respectively. By subtract-
ing the average initial threshold (.00892) from each of these values the average
Mecholyl "blocked" at each of those intervals was computed and found to be
.01042, .01422, .01142, .00352 and .00042 at 1, 2, 3, 4, and 5 hour intervals. These
results are shown in Table 2.
2 gms. Mecholyl/cc. solution.
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In the same manner the average Mecholyl "blocking effect" of 50 mgm. of
Pyribenzamine in 25 subjects was found to be .00572, .01202, .00702, .00122and
.00022 at 1, 2, 3, 4, and 5 hour intervals (Table 3).
Two control groups were tested. In each, the control consisted of a glucose
placebo capsule. One group of ten subjects was previously tested and found to
TABLE 3
Average gram8 mecholyl per c.c. solution "blocked" at hourly intervals by 50 mym. of pyri-
benzamine in 5 subjects
HOURLY THRESHOLD INITIAL 1 HOUR 2 HOUR 3 HOUR 4 HOuR 5 HOUR
Average threshold (grams mecholyl/ce.
sol.) 0110 .0167 .0230 .0180 .0122 .0112
Average initial threshold (grams
mecholyl/oc. sol.) 0110 .0110 .0110 .0110 .0110 .0110
Average mecholyl "blocked" (grams
mecholyl/ce. sol.) (difference) 0000 .0057 .0120 .0070 .0012 .0002
TABLE 4
Average grams mecholyl per cc. solution "blocked" at hourly intervals by placebos in 10
"selected" subjects
HOURLY THRESHOLD INITIAL 1 HOUR
.002
.002
.000
2 aou
.002
.002
.000
3 HOUR
.002
.002
.000
4 HOUR
.002
.002
.000
5 HOUR
.002
.002
.000
Average threshold (grams mecholyl/cc.
sol.)
Average initial threshold (grams
mecholyl/ec. sol.)
Average mecholyl "blocked" (grams
mecholyl/cc. sol.) (difference)
002
002
000
TABLE 5
Average grams mecholyl per cc. solution "blocked" at hourly intervals by placebos in 10
"unselected" subjects
HOURLY THRESHOLD INITIAL 1 HOUR 2 HOUR 3 HOUR
.0075
.0075
.0000
4 HOUR
.0075
.0075
.0000
5 HOUR
.0075
.0075
.0000
Average threshold (grams mecholyl/cc.
sol.)
Average initial threshold (grams
mecholyl/cc. sol.)
Average mecholyl "blocked" (grams
mecholyl/cc. sol.) (difference)
0075
0075
0000
.0075
.0075
.0000
.0075
.0075
.0000
demonstrate Mecholyl "blocking activity" after either Benadryl, Pyribenzamine
or both. Table 4 shows the results obtained in this group. There was no change
in the 1, 2, 3, 4, and 5 hour thresholds as compared with the initial threshold,
consequently, no Mecholyl "blocking effect" was found. The other control group
consisted of ten subjects selected at random who had not been previously tested
with this technic. Table 5 shows the results obtained in this series and again
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displays the absence of demonstrable Mecholyl "blocking effect" following
placebo therapy.
I.
I
I
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Fio. 1. Duration of mecholyl "blocking" effect of Benadryl, Pyribenzamine and controls
FIG. 2. Individual variations in the duration of the mecholyl "blocking' effect
Figure 1 shows the duration of the Mecholyl "blocking effect" of placebos
and single oral 50 mgm. doses of Benadryl and Pyribenzamine. The ordinate
represents the average Mecholyl "blocking effects" of Benadryl, Pyribenzamine
and control groups as computed in Tables 2, 3, 4, and 5.
The abscissa is the time interval in hours.
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As will be noted in Figure 1, there is a sharp decline in Mecholyl "blocking
activity" in 4 hours and almost a complete dissipation of this action in 5 hours.
However, all subjects did not return to their individual initial threshold levels
in 5 hours. This point was attained anywhere from 2—6 hours in individual in-
stances. In fact, 4 subjects in the Benadryl group and 4 in the Pyribenzamine
series showed no threshold alterations in any of the hourly determinations.
Therefore, considerable individual variations in the duration of Mecholyl "block-
ing effect" were found. These differences are shown in Fig. 2.
In a previous study Perry and Hearin (7) charted the duration of "anti-
histaminic activity" of single oral 50 mgm. doses of Benadryl and Pyribenzamine.
700
600
0o
1200
100
0o0
FIG. 3. Comparison of composite duration curves of mecholyl "blocking" and "anti-
histaminic" activities of Benadryl and Pyribenzamine
The present study shows the duration of Mecholyl "blocking effect" of the same
dosages of the same 2 drugs also administered orally (Fig. 1).
In each study the differences between the two drugs were not statistically
significant and the curves of duration of activity were quite similar. Therefore,
the data in each study were combined in order to show a single duration curve
of "antihistaminic" and Mecholyl "blocking activity" of Benadryl and Pyri-
benzamine combined. As shown in Table 6, the average initial and hourly hista-
mine threshold determinations were averaged for the combination of Benadryl
and Pyribenzamine (7). Similarly, the average initial and hourly Mecholyl
threshold determinations were averaged for the combination of the same 2 drugs.
This data is graphically shown in Fig. 3.
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DISCUSSION
The technic of Mecholyl iontophoresis, as described and utilized in these
experiments, depends upon the local production of urticaria. As previously dis-
cussed, Mecholyl is used instead of acetyicholine because it is more stable in
solution and in the body. Since the urticariogenic effect of Mecholyl is similar
to that of acetyicholine, the terms Mecholyl and acetylcholine "blocking activi-
ties or effects" are used interchangeably. Specifically, however, the technic used
measures the Mecholyl urticariogenic "blocking activity" of Benadryl and Pyri-
benzamine.
The curves of duration of Mecholyl "blocking activity" of single 50 mgm.
dosages of Benadryl and Pyribenzamine are quite similar. Any differences sug-
gested in Fig. 1 are not statistically significant. Apparently, 1 hour after the
ingestion of each of these compounds, some "blocking effect" was demonstrable.
The maximum effect was obtained in 2 hours followed by a sharp decline in 3
and 4 hours and disappearance in 5 hours. This suggests that Benadryl or Pyri-
benzamine should be administered in 4 hour intervals in order to maintain an
acetylcholine "blocking effect."
In both the "selected" and "unselected" control groups no subject was aware
of the inert nature of the placebos. In each control test the initial threshold
reaction was unaltered at subsequent hourly determinations. This indicates that
this method is reasonably devoid of errors due to psychic influences.
Individual variations in the duration of Mecholyl "blocking activity" were
noted. There were 4 subjects in each of the Benadryl and Pyribenzamine groups
who showed no "blocking effect." Two Benadryl subjects lost this effect in 2
hours as did 4 Benadryl and 1 Pyribenzamine subject in 3 hours. Initial threshold
levels were reached in 4 hours by 7 Benadryl and 11 Pyribenzamine cases, in
5 hours by 6 Benadryl and 7 Pyribenzamine subjects and in 6 hours by 3 Bena-
dryl and 2 Pyribenzamine tested individuals. Although considerable individual
variation in the duration of acetylcholine "blocking activity" of these 2 com-
pounds was found, the majority (31 of 50) of this series were in the 4 or 5 hour
group.
Some of the subjects who showed no threshold alteration following Benadryl
or Pyribenzamine were retested. There were 2 male and 2 female subjects in
the Pyribenzamine group. Two of these individuals were retested, one in 3 months
and the other 4 months later. Again in each case there was no threshold change.
One of these retested non-reactors also did not respond to intravenous Pyri-
benzamine. There were 3 males and 1 female subject in the Benadryl non-
reacting group. One was retested to Benadryl 2 weeks later and exhibited a defi-
nite Mecholyl "blocking effect." The one subject who showed no threshold
change following oral or intravenous Pyribenzamine also showed no "blocking
activity" after oral or intravenous Benadryl. The explanation for the lack of
Mecholyl "blocking effect" in the aforementioned group of non-reacting subjects
is unknown. Apparently some individuals are temporarily and perhaps per-
manently refractory, at least to Benadryl and Pyribenzamine. The demonstra-
tion of absence of Mecholyl "blocking activity" to intravenous as well as oral
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administration eliminates the possibility of defective absorption from the gastro-
intestinal tract in these subjects. Sternherg, Perry and LeVan observed examples
of similar refractoriness in histamine iontophoresis studies (2). Clinical experience
with Benadryl and Pyribenzamine in allergic syndromes also records temporary
and permanent lack of response to these 2 compounds. This problem requires
further study.
As shown in Fig. 3, the composite curves of duration of the "antihistaminic"
and in the Mecholyl "blocking activities" of Benadryl and Pyribenzamine ad-
ministered orally in 50 mgm. dosages are quite similar in their configuration.
This suggests that the technics of Mecholyl and histamine iontophoresis, as used
in these studies, measure an inhibitory action of Benadryl and Pyribenzamine
upon urticarial phenomena which might have a common denominator.
Haley and Harris (6) have demonstrated the vasoconstrictor action of "anti-
histaminic" drugs on the precapillary sphincter and the vasodilating effect of
histamine and acetyicholine upon the capillary beds in Wistar strain rats. They
feel that there is a competition between the "antihistaminic" compounds and
histamine and acetyicholine for the same site of action. In the iontophoresis
experiments local vasodilatation is produced by the introduction of histamine
or Mecholyl into the skin. The presence of the "antihistaminic" drug locally
may prevent vasodilatation until a sufficiently large concentration of histamine
or Mecholyl is introduced to overcome the vasoconstricting effect. When this
occurs, whealing appears locally. Therefore we may be actually measuring the
degree of vasoconstricting activity of "antihistaminic" compounds.
Another possible explanation for the similarity of the composite duration
curves of the "antihistaminic" arid Mecholyl "blocking effects" of Benadryl and
Pyribenzamine lies in the works of Lewis (3) and Grant, Pearson and Comeau
(8). These investigators postulated that acetyicholine introduced into the skin
by iontophoresis stimulated "skin cells" causing them to liberate H-substance
which produces the urticarial response. In a subsequent report Lewis raised
some objection to this theory because he was unable to produce whealing in
male subjects by acetyicholine iontophoresis (4). In the present experiments no
difficulty was encountered in producing an urticarial reaction in males with
Mecholyl iontophoresis. Therefore, the production of local whealing by acetyl-
choline seems to be a function of proper current, time and acetylcholine concen-
tration rather than one of sex. Thus the theory of the production of H-substance
as the urticarial producing agent in acetyicholine iontophoresis remains tenable.
Since H-substance closely resembles histamine in its action (9), the present stud-
ies may measure the "antihistaminic" effect of Benadryl and Pyribenzamine
indirectly, thereby accounting for the similar composite duration curves of the
"antihistaminic" and Mecholyl "blocking effects" of these two drugs.
CONCLUSIONS
1. The use of Mecholyl iontophoresis as described has made it possible to
determine the degree and duration of the Mecholyl "blocking effect" of single
oral 50 mgm. dosages of Benadryl and Pyribenzamine.
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2. The maximum average Mecholyl "blocking activity" was reached in 2 hours
followed by a sharp decline and disappearance in 5 hours.
3. Considerable individual variations in the duration of Mecholyl "blocking
effect" were found.
4. Control groups demonstrated no Mecholyl "blocking activity."
5. The curves of duration of Mecholyl "blocking effect" of Benadryl and Pyri-
benzamine were similar to the previously reported duration curves of "anti-
histaminic" activity of the same 2 compounds.
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DR. STEPHEN ROTHMAN: This work has been done with such great
thoroughness and accuracy that one certainly cannot argue against the validity
of its results. However, I would like to object to the expression of "acetylcholine
blocking effect" because it is misleading. The authors have measured the hista-
mine-blocking and not the acetylcholine-blocking action of antihistaminics: if
9 milligrams of mecholyl are injected into the skin and a wheal ensues this hap-
pens because that much mecholyl causes tissue damage and histamine is liber-
ated. The wheal formation has nothing to do with the physiologic effect of
acetylcholine. If the experimental arrangement of the authors permits speaking
of acetylcholine-blocking action, one also may enumerate morphine-blocking,
peptone-blocking, insect-poison-blocking or seafood-antigen-blocking action of
antihistaminics. It is known that antihistaminics have only a very moderate
acetyicholine-blocking action, which probably is clinically insignificant.
DR. THEODORE CORNBLEET: This study is worth-while in that it em-
phasizes the atropine-like action of the antihistaminics. In some instances this
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group blocks parasympathetic ganglia in the manner atropine does. On this
basis we could expect antihistaminics to be useful against excessive sweating.
If the primary action of the antihistaminics is to counteract histamine, then
their blocking action in regard to acetyleholine is a side reaction—but impor-
tant nevertheless. In some cases, where it can be used or, on the other hand proves
too injurious, such side reactions may be even more important than the primary
action. Thus antihistaminics in some instances are useful as hypnotics and
soporifics.
DR. ROTHMAN: If it were shown in carefully conducted quantitative ex-
periments that antihistaminics counteract sweating I would be glad to admit
that they have a clinically significant acetylcholine-blocking action.
DR. GEORGE C. ANDREWS: In one case of axillary hyperhydrosis I treated,
an x-ray technician who received all sorts of therapy, I finally gave her anti-
histaminics to take by mouth and she seemed to be cured by this treatment.
DR. DANIEL J. PERRY (Closing Discussion): I wish to thank the discussers
for their comments. This study and our previous ones have indicated that
"antihistaminic" compounds have an anti-urticariogenic effect, i.e., to urticaria
produced by histamine or acetylcholine iontophoresis. Haley and Harris' (1)
work suggests that antihistaminic drugs act as vasoconstrictors thereby compet-
ing with histamine and acetylcholine and preventing their vasodilating effect.
In this sense the "antihistaminics" might "block" acetylcholine and histamine.
Certainly, further studies are necessary to establish the exact site and mode of
action of the "antihistaminic" compounds. Whether we ascribe the term acetyl-
choline "blocking effect," "antiacetyicholine effect" or acetyleholine "competing
effect" to the present study is not important. This method offers another lab-
oratory approach to the evaluation of "antihistaminic" drugs about which many
confusing claims have been reported.
